光动力调节黑素瘤细胞 I 型干扰素通路促进树突状细胞的激活。
Photodynamic Modulation of Type 1 Interferon Pathway on Melanoma Cells Promotes Dendritic Cell Activation.
机构信息
Departamento de Biología Molecular, Facultad de Ciencias Exactas, Físico-Químicas y Naturales, Instituto de Biotecnología Ambiental y Salud, Consejo Nacional de Investigaciones Científicas y Técnicas, Universidad Nacional de Río Cuarto, Córdoba, Argentina.
Departamento de Bioquímica Clínica, Facultad de Ciencias Químicas, Centro de Investigaciones en Bioquímica Clínica e Inmunología, Consejo Nacional de Investigaciones Científicas y Técnicas, Universidad Nacional de Córdoba, Córdoba, Argentina.
出版信息
Front Immunol. 2019 Nov 8;10:2614. doi: 10.3389/fimmu.2019.02614. eCollection 2019.
The immune response against cancer generated by type-I-interferons (IFN-1) has recently been described. Exogenous and endogenous IFN-α/β have an important role in immune surveillance and control of tumor development. In addition, IFN-1s have recently emerged as novel DAMPs for the consecutive events connecting innate and adaptive immunity, and they also have been postulated as an essential requirement for induction of immunogenic cell death (ICD). In this context, photodynamic therapy (PDT) has been previously linked to the ICD. PDT consists in the administration of a photosensitizer (PS) and its activation by irradiation of the affected area with visible light producing excitation of the PS. This leads to the local generation of harmful reactive oxygen species (ROS) with limited or no systemic defects. In the current work, Me-ALA inducing PpIX (endogenous PS) was administrated to B16-OVA melanoma cells. PpIX preferentially localized in the endoplasmic reticulum (ER). Subsequent PpIX activation with visible light significantly induced oxidative ER-stress mediated-apoptotic cell death. Under these conditions, the present study was the first to report the upregulation of IFN-1 expression in response to photodynamic treatment in melanoma. This α/β transcripts upregulation was concurrent with IRF-3 phosphorylation at levels that efficiently activated STAT1 and increased ligand receptor (cGAS) and ISG (CXCL10, MX1, ISG15) expression. The IFN-1 pathway has been identified as a critical molecular pathway for the antitumor host immune response, more specifically for the dendritic cells (DCs) functions. In this sense, PDT-treated melanoma cells induced IFN-1-dependent phenotypic maturation of monocyte-derived dendritic cells (DCs) by enhancing co-stimulatory signals (CD80, MHC-II) and tumor-directed chemotaxis. Collectively, our findings showed a new effect of PDT-treated cancer cells by modulating the IFN-1 pathway and its impact on the activation of DCs, emphasizing the potential relevance of PDT in adoptive immunotherapy protocols.
I 型干扰素(IFN-1)引发的抗癌免疫反应最近被描述。外源性和内源性 IFN-α/β 在免疫监视和肿瘤发展的控制中具有重要作用。此外,IFN-1s 最近作为连接先天免疫和适应性免疫的连续事件的新型 DAMPs 出现,并且它们也被假定为诱导免疫原性细胞死亡(ICD)的基本要求。在这种情况下,光动力疗法(PDT)以前与 ICD 有关。PDT 包括给予光敏剂(PS),并用可见光照射受影响的区域激活 PS,从而产生有害的活性氧(ROS)的局部产生,其具有有限的或没有全身缺陷。在目前的工作中,Me-ALA 诱导 PpIX(内源性 PS)被给予 B16-OVA 黑色素瘤细胞。PpIX 优先定位于内质网(ER)。随后用可见光激活 PpIX 显著诱导氧化 ER 应激介导的凋亡细胞死亡。在这些条件下,本研究首次报道了黑色素瘤对光动力治疗的 IFN-1 表达上调。这些 α/β 转录物的上调与 IRF-3 磷酸化同时发生,其有效地激活了 STAT1 并增加了配体受体(cGAS)和 ISG(CXCL10、MX1、ISG15)的表达。IFN-1 途径已被确定为抗肿瘤宿主免疫反应的关键分子途径,更具体地说是树突状细胞(DCs)功能的关键分子途径。在这种意义上,PDT 处理的黑色素瘤细胞通过增强共刺激信号(CD80、MHC-II)和肿瘤定向趋化性诱导 IFN-1 依赖性单核细胞衍生树突状细胞(DCs)的表型成熟。总的来说,我们的研究结果表明 PDT 处理的癌细胞通过调节 IFN-1 途径及其对 DCs 激活的影响产生了新的作用,强调了 PDT 在过继免疫治疗方案中的潜在相关性。